Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players√Ę‚ā¨‚ĄĘ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

Skin Biopsy Market Research Report Information: By Type (Shave Biopsy, Excisional Biopsy, Incisional Biopsy), Device (Needle Based Biopsy Guns, Biopsy Forceps, Biopsy Needles), Indication (Cancer, Actinic Keratosis, Skin Infection), End User - Forecast till 2030


ID: MRFR/MED/3229-HCR | 110 Pages | Author: Kinjoll Dey| April 2024

Skin Biopsy Market Overview


The skin biopsy market is projected to reach USD 162.7 Million by 2030 at 9.89% CAGR during the forecast period 2022-2030.Skin biopsy is a procedure involving the removal of skin for examination and providing information about any disease or clinical conditions. It is performed to determine the presence of any cancerous cells or any type of skin diseases. Skin cancer, actinic keratosis, dermatitis, psoriasis, and skin infection are various diseases that can be diagnosed through skin biopsy. During the procedure, the sample taken from the affected or diseased part of the skin is placed in formaldehyde solution, the tissue is processed and then examined under the microscope. 

Rising of skin cancer and number of skin disease such as psoriasis, viral skin infection, and dermatitis, and growing demand for minimally invasive medical procedures are major factors contributing to the market growth. Furthermore, rising expenditure on the medical devices and instruments boost the market growth. However, high cost of treatment for skin diseases restrains the market.

Key Players in the Global Skin Biopsy Market 

Some of the key players in skin biopsy market are Boston Scientific Corporation (U.S.), COOK Medical (U.S.), BD (U.S.), DTR Medical Ltd (U.K), Devicor Medical Products, Inc. part of Leica Biosystems. (U.S.), Gallini Srl (Italy), Hologic, Inc. (U.S.), and Cardinal Health (U.S.).


 Segments      


The global skin biopsy market is segmented on the basis of type, devices, indication, and end user.


On the basis of type, skin biopsy market is segmented into shave biopsy, punch biopsy, excisional biopsy and incisional biopsy.


On the basis of devices, the skin biopsy market is segmented into needle based biopsy guns, biopsy curettes and punches, guidance systems, biopsy forceps, biopsy needles and others.


On the basis of indication, the skin biopsy market is segmented into actinic keratosis, dermatitis, psoriasis, skin infection, cancer, and others.


 Skin infection is further segmented into viral infections, deep fungal infections, basal cell carcinoma, squamous cell carcinoma, and melanoma.


On the basis of end user, the market is segmented into hospitals, dermatology clinics, and others.


Regional Analysis of the Global Skin Biopsy Market           


America secures a leading position in the market for skin biopsy owing to the rising prevalence of skin diseases and cancer in the U.S. and presence of key market players. According to the American Academy of Dermatology (AAD), skin diseases affects one in every fourth American. The prevalence of skin diseases is also found to be increasing in Canada.


Europe is the second largest market for skin biopsy. Increasing prevalence of skin diseases such as fungal infections, and dermatitis, and increasing demand for technological advanced diagnostic services further drive the market growth.


The skin biopsy market in Asia Pacific is expected to grow at the fastest pace and is driven by the rising geriatric population, rising prevalence of skin cancer, and increasing number of biopsies performed in the hospitals.


The Middle East & Africa also show a steady rise in the skin biopsy market owing to increasing prevalence of diabetes and other chronic diseases


Intended Audience



  • Biopsy Devices Manufacturers

  • Biopsy Devices Suppliers

  • Private Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Government Research Laboratories

Report Attribute/Metric Details
  Market Size   2030: USD 162.7 Million
  CAGR   2022-2030: 9.89%
  Base Year   2021
  Forecast Period   2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Devices, Indication, And End User
  Geographies Covered  North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Boston Scientific Corporation (U.S.), COOK Medical (U.S.), BD (U.S.), DTR Medical Ltd (U.K), Devicor Medical Products, Inc. part of Leica Biosystems. (U.S.), Gallini Srl (Italy), Hologic, Inc. (U.S.), and Cardinal Health (U.S.)
  Key Market Opportunities   Rising expenditure on the medical devices and instruments
  Key Market Drivers Rising of skin cancer and number of skin disease such as psoriasis, viral skin infection, and dermatitisGrowing demand for minimally invasive medical procedures


Frequently Asked Questions (FAQ) :

Skin biopsy market is projected to grow at approximately 9.89% CAGR during the assessment period (2022-2030).

Increasing prevalence of skin diseases, rising awareness about skin cancer & its treatment, and growing demand for technologically advanced medical devices, are the major tailwinds pushing the growth of the global skin biopsy market.

High cost of treatment for skin diseases is a major growth impeder for the global skin biopsy market.

North America holds the largest share in the global skin biopsy market, followed by Europe and the Asia Pacific, respectively.

COOK Medical (U.S.), Boston Scientific Corporation (U.S.), BD (U.S.), Devicor Medical Products, Inc. part of Leica Biosystems. (U.S.), DTR Medical Ltd (U.K), Gallini Srl (Italy), Cardinal Health (U.S.), and Hologic, Inc. (U.S.), are some of the top players operating in the global skin biopsy market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization